Nihon Kohden Introduces Two New Biphasic Defibrillator Series.Tokyo Tokyo (tō`kēō), city (1990 pop. 8,163,573), capital of Japan and of Tokyo prefecture, E central Honshu, at the head of Tokyo Bay. , Japan, Dec 2, 2005 - (JCN JCN Japan Corporate News JCN Journal of Cognitive Neuroscience JCN Journal of Cardiovascular Nursing JCN Journal of Christian Nursing JCN Job Control Number JCN Journal of Child Neurology JCN joint communications network (US DoD) ) - Nihon Kohden announced on December 1 that it has launched the TEC-7700 and the TEC-2300 series of biphasic bi·pha·sic adj. Having two distinct phases: a biphasic waveform; a biphasic response to a stimulus. defibrillators. Nihon Kohden has become the first Japanese manufacturer that has developed and commercialized biophasic biophasic pertaining to the biophase of a drug. biophasic availability the characteristic of a drug which determines its biophase. defibrillators. Compared with the conventional monophasic mon·o·pha·sic adj. 1. Of or affected by monophasia. 2. Having only one phase or stage. 3. Of or being a disorder with a single phase. defibrillators, the biophasic cousins can deliver the shock to the heart muscle with less energy so they can reduce the damage on heart. The TEC-7700 series, which features four models priced from 1,450,000 yen ($12,000) to 2,700,000 yen ($22,600), is designed for use in emergency rooms, operation rooms, ICUs and CCUs. The TEC-2300 series, which includes two models priced from 2,020,000 yen ($16,900) and 2,220,000 yen ($18,600), respectively, is inteded for use in ambulance cars and outside. The company aims to sell more than 3,000 units in total over the next three years. Copyright [c] 2005 Japan Corporate News Network. All rights reserved. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion